205 related articles for article (PubMed ID: 27638610)
1. Krabbe's leukodystrophy: Approaches and models in vitro.
Avola R; Graziano AC; Pannuzzo G; Alvares E; Cardile V
J Neurosci Res; 2016 Nov; 94(11):1284-92. PubMed ID: 27638610
[TBL] [Abstract][Full Text] [Related]
2. Peroxisomal participation in psychosine-mediated toxicity: implications for Krabbe's disease.
Khan M; Haq E; Giri S; Singh I; Singh AK
J Neurosci Res; 2005 Jun; 80(6):845-54. PubMed ID: 15898099
[TBL] [Abstract][Full Text] [Related]
3. Biochemical pathogenesis of demyelination in globoid cell leukodystrophy (Krabbe's disease): the effects of psychosine upon oligodendroglial cell culture.
Ida H; Eto Y; Maekawa K
Acta Paediatr Jpn; 1990 Feb; 32(1):20-6. PubMed ID: 2109485
[TBL] [Abstract][Full Text] [Related]
4. Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.
Won JS; Singh AK; Singh I
J Neurosci Res; 2016 Nov; 94(11):990-1006. PubMed ID: 27638584
[TBL] [Abstract][Full Text] [Related]
5. Psychosine enhances the shedding of membrane microvesicles: Implications in demyelination in Krabbe's disease.
D'Auria L; Reiter C; Ward E; Moyano AL; Marshall MS; Nguyen D; Scesa G; Hauck Z; van Breemen R; Givogri MI; Bongarzone ER
PLoS One; 2017; 12(5):e0178103. PubMed ID: 28531236
[TBL] [Abstract][Full Text] [Related]
6. Beyond Krabbe's disease: The potential contribution of galactosylceramidase deficiency to neuronal vulnerability in late-onset synucleinopathies.
Marshall MS; Bongarzone ER
J Neurosci Res; 2016 Nov; 94(11):1328-32. PubMed ID: 27638614
[TBL] [Abstract][Full Text] [Related]
7. Lysosphingolipids and sphingolipidoses: Psychosine in Krabbe's disease.
Spassieva S; Bieberich E
J Neurosci Res; 2016 Nov; 94(11):974-81. PubMed ID: 27638582
[TBL] [Abstract][Full Text] [Related]
8. Biochemical pathogenesis of genetic leukodystrophies: comparison of metachromatic leukodystrophy and globoid cell leukodystrophy (Krabbe's disease).
Suzuki K
Neuropediatrics; 1984 Sep; 15 Suppl():32-6. PubMed ID: 6152811
[TBL] [Abstract][Full Text] [Related]
9. Optic nerve in globoid leukodystrophy (Krabbe's disease). Ultrastructural changes.
Brownstein S; Meagher-Villemure K; Polomeno RC; Little JM
Arch Ophthalmol; 1978 May; 96(5):864-70. PubMed ID: 418756
[TBL] [Abstract][Full Text] [Related]
10. Krabbe's disease; A rare case report.
Jaiswani AK; Kulkarni V; Paliwal A
Leg Med (Tokyo); 2023 Feb; 60():102155. PubMed ID: 36272395
[TBL] [Abstract][Full Text] [Related]
11. Tissue culture model of Krabbe's disease: psychosine cytotoxicity in rat oligodendrocyte culture.
Cho KH; Kim MW; Kim SU
Dev Neurosci; 1997; 19(4):321-7. PubMed ID: 9215877
[TBL] [Abstract][Full Text] [Related]
12. Clinical, electrophysiological, and biochemical markers of peripheral and central nervous system disease in canine globoid cell leukodystrophy (Krabbe's disease).
Bradbury AM; Bagel JH; Jiang X; Swain GP; Prociuk ML; Fitzgerald CA; O'Donnell PA; Braund KG; Ory DS; Vite CH
J Neurosci Res; 2016 Nov; 94(11):1007-17. PubMed ID: 27638585
[TBL] [Abstract][Full Text] [Related]
13. Fingolimod Rescues Demyelination in a Mouse Model of Krabbe's Disease.
Béchet S; O'Sullivan SA; Yssel J; Fagan SG; Dev KK
J Neurosci; 2020 Apr; 40(15):3104-3118. PubMed ID: 32127495
[TBL] [Abstract][Full Text] [Related]
14. Axonal pathology in Krabbe's disease: The cytoskeleton as an emerging therapeutic target.
Nogueira-Rodrigues J; Brites P; Sousa MM
J Neurosci Res; 2016 Nov; 94(11):1037-41. PubMed ID: 27638589
[TBL] [Abstract][Full Text] [Related]
15. Increased TNF-alpha production by peripheral blood mononuclear cells in patients with Krabbe's disease: effect of psychosine.
Pasqui AL; Di Renzo M; Auteri A; Federico G; Puccetti L
Eur J Clin Invest; 2007 Sep; 37(9):742-5. PubMed ID: 17696965
[TBL] [Abstract][Full Text] [Related]
16. Neuroimmune mechanisms in Krabbe's disease.
Potter GB; Petryniak MA
J Neurosci Res; 2016 Nov; 94(11):1341-8. PubMed ID: 27638616
[TBL] [Abstract][Full Text] [Related]
17. Immunological considerations for treating globoid cell leukodystrophy.
Karumuthil-Melethil S; Gray SJ
J Neurosci Res; 2016 Nov; 94(11):1349-58. PubMed ID: 27638617
[TBL] [Abstract][Full Text] [Related]
18. Can psychosine and galactocerebrosidase activity predict early-infantile Krabbe's disease presymptomatically?
Carter RL; Wrabetz L; Jalal K; Orsini JJ; Barczykowski AL; Matern D; Langan TJ
J Neurosci Res; 2016 Nov; 94(11):1084-93. PubMed ID: 27638594
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathies.
Abdelkarim H; Marshall MS; Scesa G; Smith RA; Rue E; Marshall J; Elackattu V; Stoskute M; Issa Y; Santos M; Nguyen D; Hauck Z; van Breemen R; Celej MS; Gaponenko V; Bongarzone ER
Sci Rep; 2018 Aug; 8(1):12462. PubMed ID: 30127535
[TBL] [Abstract][Full Text] [Related]
20. Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients.
Formichi P; Radi E; Battisti C; Pasqui A; Pompella G; Lazzerini PE; Laghi-Pasini F; Leonini A; Di Stefano A; Federico A
J Cell Physiol; 2007 Sep; 212(3):737-43. PubMed ID: 17458901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
